Cripto-1 as a novel therapeutic target for triple negative breast cancer

Triple-negative breast cancer (TNBC) presents the poorest prognosis among the breast cancer subtypes and no current standard therapy. Here, we performed an in-depth molecular analysis of a mouse model that establishes spontaneous lung metastasis from JygMC(A) cells. These primary tumors resembled th...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Castro, Nadia P., Fedorova-Abrams, Natalie D., Merchant, Anand S., Rangel, Maria Cristina, Nagaoka, Tadahiro, Karasawa, Hideaki, Klauzinska, Malgorzata, Hewitt, Stephen M., Biswas, Kajal, Sharan, Shyam K., Salomon, David S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2014
Soggetti:
Priority Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4494913/
https://ncbi.nlm.nih.gov/pubmed/26059540
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi